Home
PharmaEssentia

PharmaEssentia Market Share Analysis for August 2026

PharmaEssentia is a global biopharmaceutical company developing best-in-class therapies for blood disorders and other serious diseases worldwide.

Health > Biotechnology and Pharmaceuticals

Domainpharmaessentia.com

Year Founded2003

Employees501 - 1000

Annual Revenue$15M - $25M

PharmaEssentia

PharmaEssentia (including company regionals)

pharmaessentia.com

See more website traffic and engagement information

PharmaEssentia Revenue up to August 2026 is 15M - 25M

revenue generated by PharmaEssentia top domains

PharmaEssentia top domains revenue over 3 years

Revenue for PharmaEssentia top domains

pharmaessentia.com15M - 25M

See more with Sales Intelligence

Total visits to PharmaEssentia's top domains

Understand PharmaEssentia market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pharmaessentia.com25.6K

See more with Sales Intelligence

Avg. visit duration in PharmaEssentia's top domains

Analyze PharmaEssentia engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pharmaessentia.com00:02:25

See more with Sales Intelligence

Avg. pageviews on PharmaEssentia's top domains

See how PharmaEssentia keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pharmaessentia.com2.11

See more with Sales Intelligence

PharmaEssentia top competitors by domain

Top similar sites in August 2026, ranked by their affinity

mpnresearchfoundation.orgCompany NameMPN Research FoundationEmployees51 - 200HQUnited States, Illinois, ChicagoAnnual revenue$2M - $5MTotal visits15.9KHealth > Health Conditions and Concerns

Top technologies used by PharmaEssentia

These are the website technologies, by industry, used by PharmaEssentia top domains

Payment & Currencies (8)

Cart Functionality

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

11

See all

News & Signals from PharmaEssentia

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPharmaEssentia Corporation had issues with intentional breaches of contract on Feb 1st '25.The award quantifies AOP Health's damages claims arising from PharmaEssentia's intentional breaches of contract at approximately EUR 82 million.

NewsPharmaEssentia Corporation had revenue of $15.6B on Jul 1st '25.Regarding the impact of this case on the company's financial and business operations, PharmaEssentia stated that the company's full-year revenue in 2025 reached NT$15.6 billion, and cumulative revenue from January to July 2026 was nearly NT$14.5 billion, indicating a sound financial condition.

NewsPharmaEssentia Corporation launched BESREMi Pen for Polycythemia Vera on Jun 26th '26.PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen(TM)(ropeginterferon alfa-2b-njft) for Polycythemia Vera.